IOFINA PLC

Report Publication Announcement • May 16, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3675H

Iofina PLC

16 May 2014

16 May 2014

Iofina plc

("Iofina" or the "Group")

(LSE AIM: IOF)

Posting of Annual Report & Notice of AGM

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, announces that it has posted its Annual Report and Accounts for the year ended 31 December 2013 together with the Notice of Annual General Meeting (AGM) and associated form of proxy.

A copy of the Annual Report and the Notice and related documents are available on the Company's website www.iofina.com.

The AGM will be held at the Hallam Conference Centre (Council Chamber), 44 Hallam Street, London W1W 6JJ on 10 June 2014 at 10.30 a.m.

For further information, please contact:

Jeff Ploen, Interim CEO and President

Iofina

Tel: +44 (0) 20 3006 3135

www.iofina.com 

John Prior/Rupert Krefting/Huw Jeremy

Numis Securities

Tel: +44(0)20 7260 1000

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

About Iofina

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOASFMFEMFLSEII